Joon Lee
#22 out of 1697 analysts
Truist Securities
Automatically Tracked
Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
Gain and growth charts are calculated per selected timeframe:
230.44%
Gain -1.6%
Monthly
-0.27%
Yearly
-3.14%
Drawdown
75.55%
$84,252.04
Equity
Holdings
$0
Cash
$84,252.04
Investment
$0
-$15,748.02
Profit -$1,373.01
Realized
-$15,748.02
Unrealized
$0
Dividends
$0
$84,252.04
Cash
Deposits
$100,000.06
Withdrawals
$0
Commissions
$0
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
-1.6%
Profit
-$1,373.01
Win %
66%
This Week
Compared To Last Week
Gain
3.65%
Profit
$2,969.89
Win %
66%
This Month
Compared to last month
Gain
0.82%
Profit
$682.78
Win %
66%
This Year
Compared to last year
Gain
10%
Profit
$7,659.51
Win %
62%
VKTX Viking Therapeutics Inc.
+$20,153.31
AXSM Axsome Therapeutics, Inc.
+$16,251.24
PRAX Praxis Precision Medicines Inc.
+$14,816.94
PTCT PTC Therapeutics, Inc.
+$8,962.54
NTLA Intellia Therapeutics Inc.
+$8,586.46
ANAB AnaptysBio Inc.
+$7,126.9
ARGX argenx SE American Depositary Receipt
+$6,646.16
TSHA Taysha Gene Therapies Inc.
+$4,718.07
CORT Corcept Therapeutics Incorporated
+$4,242.04
VRTX Vertex Pharmaceuticals Incorporated
+$2,925.71
RAPP Rapport Therapeutics Inc.
+$2,197.03
JAZZ Jazz Pharmaceuticals plc
+$1,552.39
VYGR Voyager Therapeutics Inc.
+$620.01
CPRX Catalyst Pharmaceuticals Inc.
+$301.45
CYCN Cyclerion Therapeutics Inc.
-$51,989.52
EDIT Editas Medicine Inc.
-$21,782.98
CRMD CorMedix Inc.
-$16,902.1
WVE Wave Life Sciences Ltd.
-$7,428.42
LRMR Larimar Therapeutics Inc.
-$4,552.43
RARE Ultragenyx Pharmaceutical Inc.
-$4,504.46
ARVN Arvinas Inc.
-$2,710.94
SLDB Solid Biosciences Inc.
-$2,167.15
BMRN Biomarin Pharmaceutical Inc.
-$1,342.51
CRSP Crispr Therapeutics AG
-$771.62
ALKS Alkermes plc
-$696.13
Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 733 | Longs Won 388/733 52% | Profit Factor 0.92 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1,658.28 |
| Average Win $448.21 | Best Trade (Sep 18) $8,618.41 | Sharpe Ratio -231.58 |
| Average Loss -$549.72 | Worst Trade (Jan 28) -$23,514.95 | Z-Score -6.8 (100%) |
| Commissions $0 | Avg. Trade Length 2m 6d | Expectancy -$21.48 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 153 | 138 | 123 | 107 | 92 | 77 | 61 | 46 | 31 | 15 |
Hover over the desired column for a detailed explanation.
Returns
Overall, Monthly| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
